<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RSV Hospitalizations Plummet Thanks to New Vaccines | News That's Not Crap</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
    <style>
        :root {
            --wgac-brown: #a1512e;
            --wgac-green-light: #d7f6a4;
            --wgac-blue: #4368ff;
            --wgac-teal: #2dcb98;
            --wgac-coral: #e85d4c;
            --wgac-yellow: #f0c808;
            --wgac-purple: #7b68ee;
            --wgac-pink: #e84393;
            --cream: #faf9f6;
            --dark: #1a1a1a;
            --gray-100: #f5f4f2;
            --gray-200: #e8e6e3;
            --gray-400: #a09d98;
            --gray-600: #6b6761;
            --font-display: 'Instrument Serif', Georgia, serif;
            --font-body: 'IBM Plex Sans', -apple-system, BlinkMacSystemFont, sans-serif;
        }

        * { margin: 0; padding: 0; box-sizing: border-box; }

        body {
            font-family: var(--font-body);
            background: var(--cream);
            color: var(--dark);
            line-height: 1.6;
            -webkit-font-smoothing: antialiased;
        }

        a { color: inherit; text-decoration: none; }

        /* Header */
        .site-header {
            background: var(--dark);
            padding: 0;
            position: sticky;
            top: 0;
            z-index: 1000;
        }

        .header-top {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 1.25rem 3rem;
            border-bottom: 1px solid rgba(255,255,255,0.1);
        }

        .logo {
            display: flex;
            align-items: stretch;
            font-family: var(--font-body);
            font-size: 1rem;
            font-weight: 800;
            text-decoration: none;
        }

        .logo-left {
            background: white;
            color: var(--dark);
            padding: 0.5rem 0.75rem;
            display: flex;
            align-items: center;
            letter-spacing: 0.5px;
        }

        .logo-right {
            background: var(--wgac-blue);
            color: white;
            padding: 0.5rem 0.75rem;
            display: flex;
            align-items: center;
            letter-spacing: 0.5px;
        }

        .header-date {
            color: var(--gray-400);
            font-size: 0.8rem;
            font-weight: 500;
            letter-spacing: 0.5px;
            text-transform: uppercase;
        }

        /* Navigation */
        .main-nav {
            display: flex;
            justify-content: center;
            gap: 2px;
            padding: 0.75rem 0;
            background: var(--dark);
        }

        .nav-link {
            font-size: 0.7rem;
            font-weight: 700;
            letter-spacing: 0.5px;
            text-transform: uppercase;
            padding: 0.5rem 1rem;
            transition: all 0.15s ease;
            background: rgba(255,255,255,0.1);
            color: white;
        }

        .nav-link:hover {
            background: white;
            color: var(--dark);
        }

        .nav-link.active {
            background: var(--wgac-blue);
            color: white;
        }

        /* Article Hero */
        .article-hero {
            position: relative;
            height: 70vh;
            min-height: 500px;
            max-height: 700px;
            overflow: hidden;
        }

        .article-hero img {
            width: 100%;
            height: 100%;
            object-fit: cover;
        }

        .article-hero-overlay {
            position: absolute;
            inset: 0;
            background: linear-gradient(to top, rgba(0,0,0,0.8) 0%, rgba(0,0,0,0.3) 50%, rgba(0,0,0,0.1) 100%);
        }

        .article-hero-content {
            position: absolute;
            bottom: 0;
            left: 0;
            right: 0;
            padding: 4rem;
            max-width: 900px;
            margin: 0 auto;
            text-align: center;
        }

        .article-tag {
            display: inline-block;
            background: var(--wgac-coral);
            color: white;
            padding: 0.35rem 0.75rem;
            font-weight: 700;
            font-size: 0.65rem;
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 1.5rem;
        }

        .article-hero h1 {
            font-family: var(--font-display);
            font-size: clamp(2.5rem, 5vw, 3.5rem);
            font-weight: 400;
            line-height: 1.15;
            color: white;
            margin-bottom: 1.5rem;
        }

        .article-meta {
            color: rgba(255,255,255,0.7);
            font-size: 0.9rem;
        }

        .article-meta span { margin: 0 0.75rem; }

        /* Article Content */
        .article-content {
            max-width: 700px;
            margin: 0 auto;
            padding: 4rem 2rem;
        }

        .article-lead {
            font-size: 1.35rem;
            line-height: 1.7;
            color: var(--dark);
            margin-bottom: 2rem;
            font-weight: 400;
        }

        .article-body p {
            font-size: 1.1rem;
            line-height: 1.8;
            margin-bottom: 1.5rem;
            color: var(--gray-600);
        }

        .article-body h2 {
            font-family: var(--font-display);
            font-size: 1.75rem;
            margin: 3rem 0 1.5rem;
            color: var(--dark);
        }

        .article-body blockquote {
            border-left: 3px solid var(--wgac-coral);
            padding-left: 1.5rem;
            margin: 2rem 0;
            font-family: var(--font-display);
            font-size: 1.4rem;
            font-style: italic;
            color: var(--dark);
        }

        /* Stats Box */
        .stats-box {
            background: var(--wgac-coral);
            color: white;
            padding: 2.5rem;
            margin: 3rem 0;
        }

        .stats-box h3 {
            font-family: var(--font-display);
            font-size: 1.25rem;
            margin-bottom: 1.5rem;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 2rem;
        }

        .stat-item { text-align: center; }

        .stat-number {
            font-family: var(--font-display);
            font-size: 3rem;
            line-height: 1;
            margin-bottom: 0.5rem;
        }

        .stat-label {
            font-size: 0.8rem;
            opacity: 0.9;
        }

        /* Image with caption */
        .article-figure {
            margin: 3rem -4rem;
        }

        .article-figure img {
            width: 100%;
            display: block;
        }

        .article-figure figcaption {
            font-size: 0.85rem;
            color: var(--gray-400);
            padding: 1rem 4rem;
            text-align: center;
        }

        .sources-box {
            margin-top: 3rem;
            padding: 2rem;
            background: var(--gray-100);
            border-left: 4px solid var(--wgac-coral);
        }

        .sources-box h3 {
            font-family: var(--font-body);
            font-size: 0.8rem;
            font-weight: 700;
            text-transform: uppercase;
            letter-spacing: 1px;
            color: var(--gray-600);
            margin-bottom: 1rem;
        }

        .sources-box ul {
            list-style: none;
        }

        .sources-box li {
            margin-bottom: 0.5rem;
        }

        .sources-box a {
            color: var(--wgac-coral);
            font-size: 0.9rem;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: border-color 0.2s ease;
        }

        .sources-box a:hover {
            border-bottom-color: var(--wgac-coral);
        }

        /* Related Articles */
        .related-section {
            background: var(--gray-100);
            padding: 4rem 2rem;
            margin-top: 4rem;
        }

        .related-inner {
            max-width: 1200px;
            margin: 0 auto;
        }

        .related-title {
            font-family: var(--font-display);
            font-size: 1.5rem;
            margin-bottom: 2rem;
            padding-bottom: 1rem;
            border-bottom: 2px solid var(--dark);
        }

        .related-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 2rem;
        }

        .related-card {
            background: white;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .related-card:hover { background: var(--cream); }
        .related-card:hover h4 { color: var(--wgac-brown); }

        .related-card img {
            width: 100%;
            height: 180px;
            object-fit: cover;
            display: block;
        }

        .related-card-content {
            padding: 1.25rem;
        }

        .related-card h4 {
            font-family: var(--font-display);
            font-size: 1.1rem;
            line-height: 1.35;
            transition: color 0.2s ease;
        }

        /* Footer */
        .site-footer {
            background: var(--dark);
            color: white;
            padding: 4rem 3rem;
        }

        .footer-content {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
        }

        .footer-brand {
            max-width: 350px;
        }

        .footer-logo {
            display: flex;
            align-items: stretch;
            font-family: var(--font-body);
            font-size: 0.85rem;
            font-weight: 800;
            margin-bottom: 1rem;
            width: fit-content;
        }

        .footer-logo .logo-left {
            background: white;
            color: var(--dark);
            padding: 0.4rem 0.6rem;
        }

        .footer-logo .logo-right {
            background: var(--wgac-blue);
            color: white;
            padding: 0.4rem 0.6rem;
        }

        .footer-tagline {
            font-size: 0.9rem;
            color: var(--gray-400);
            line-height: 1.6;
        }

        .footer-nav {
            display: flex;
            gap: 4rem;
        }

        .footer-col h4 {
            font-size: 0.7rem;
            font-weight: 700;
            letter-spacing: 1px;
            text-transform: uppercase;
            color: var(--gray-400);
            margin-bottom: 1rem;
        }

        .footer-col ul {
            list-style: none;
        }

        .footer-col li {
            margin-bottom: 0.5rem;
        }

        .footer-col a {
            font-size: 0.9rem;
            color: white;
            opacity: 0.8;
            transition: opacity 0.2s ease;
        }

        .footer-col a:hover {
            opacity: 1;
        }

        .footer-bottom {
            max-width: 1400px;
            margin: 3rem auto 0;
            padding-top: 2rem;
            border-top: 1px solid rgba(255,255,255,0.1);
            font-size: 0.8rem;
            color: var(--gray-400);
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .footer-update {
            font-size: 0.7rem;
            opacity: 0.6;
            letter-spacing: 0.5px;
        }

        /* Responsive */
        @media (max-width: 1024px) {
            .related-grid {
                grid-template-columns: 1fr;
            }
            .footer-content {
                flex-direction: column;
                gap: 3rem;
            }
        }

        @media (max-width: 768px) {
            .header-top { padding: 1rem 1.5rem; }
            .main-nav { flex-wrap: wrap; }
            .nav-link { padding: 0.75rem 1rem; font-size: 0.7rem; }
            .article-hero-content { padding: 2rem 1.5rem; }
            .article-content { padding: 2rem 1.5rem; }
            .article-figure { margin: 2rem -1.5rem; }
            .article-figure figcaption { padding: 1rem 1.5rem; }
            .stats-grid { grid-template-columns: 1fr; gap: 1.5rem; }
        }
    </style>
</head>
<body>
    <!-- Header -->
    <header class="site-header">
        <div class="header-top">
            <a href="../index.html" class="logo"><span class="logo-left">NEWS THAT'S NOT</span><span class="logo-right">CRAP</span></a>
            <div class="header-date">Wednesday, January 29, 2026</div>
        </div>
        <nav class="main-nav">
            <a href="../index.html" class="nav-link">Today</a>
            <a href="../climate.html" class="nav-link">Climate</a>
            <a href="../health.html" class="nav-link active">Health</a>
            <a href="../science.html" class="nav-link">Science</a>
            <a href="../people.html" class="nav-link">People</a>
            <a href="../wildlife.html" class="nav-link">Wildlife</a>
            <a href="../cats.html" class="nav-link">Cats</a>
        </nav>
    </header>

    <!-- Article Hero -->
    <div class="article-hero">
        <img src="https://images.unsplash.com/photo-1584515933487-779824d29309?w=1920&q=80" alt="Happy infant being held by parent">
        <div class="article-hero-overlay"></div>
        <div class="article-hero-content">
            <span class="article-tag">Health</span>
            <h1>RSV Hospitalizations Plummet Thanks to New Vaccines</h1>
            <div class="article-meta">
                <span>By Bea Wellsoon</span>
                <span>·</span>
                <span>January 29, 2026</span>
                <span>·</span>
                <span>4 min read</span>
            </div>
        </div>
    </div>

    <!-- Article Content -->
    <article class="article-content">
        <p class="article-lead">
            For decades, RSV was the boogeyman of pediatric wards—the leading cause of infant hospitalization that we couldn't do much about. Now, thanks to a one-two punch of maternal vaccines and infant antibody treatments, that boogeyman is getting absolutely clobbered.
        </p>

        <div class="article-body">
            <p>
                The numbers coming out of the 2024-2025 respiratory season are nothing short of remarkable. According to CDC data comparing RSV-associated hospitalization rates among infants during 2024-25 with pre-COVID-19 pandemic seasons, rates were lower by an estimated 28% to 43% for infants under 8 months old. For the tiniest babies—under 3 months—hospitalizations dropped by 45% to 52%.
            </p>

            <p>
                RSV is the leading cause of infant hospitalization in the United States. The fact that we're cutting that hospitalization rate nearly in half for the youngest infants is nothing short of transformational.
            </p>

            <blockquote>
                "We used to dread RSV season the way farmers dread locusts. Now it feels like we've finally found the pesticide."
            </blockquote>

            <p>
                The turnaround is the result of two breakthrough products that became widely available during the 2024-25 RSV season. Beyfortus (nirsevimab) is a long-acting monoclonal antibody injection given to infants that provides protection for an entire RSV season. Abrysvo is a maternal vaccine given during pregnancy that passes protective antibodies to babies before they're born.
            </p>

            <div class="stats-box">
                <h3>By The Numbers</h3>
                <div class="stats-grid">
                    <div class="stat-item">
                        <div class="stat-number">52%</div>
                        <div class="stat-label">Drop for infants under 3 months</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">43%</div>
                        <div class="stat-label">Drop for infants under 8 months</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">66%</div>
                        <div class="stat-label">Of eligible infants protected by Feb 2025</div>
                    </div>
                </div>
            </div>

            <h2>Why RSV Was Such a Terror</h2>

            <p>
                If you're not a parent or pediatrician, you might not fully appreciate how scary RSV has been. For most adults and older children, it causes symptoms indistinguishable from a common cold. But for infants—especially those under six months—it can be devastating.
            </p>

            <p>
                RSV is the leading cause of bronchiolitis (inflammation of small airways) and pneumonia in infants worldwide. Before the prevention products, it killed an estimated 100,000 children globally every year, most of them in developing countries. In the U.S., it was the number one reason babies ended up in the hospital.
            </p>

            <p>
                "Every winter, we'd watch these tiny babies struggling to breathe," pediatric specialists recall. "We could provide supportive care—oxygen, fluids, monitoring—but we had nothing to prevent it. Decades of vaccine attempts had failed."
            </p>

            <figure class="article-figure">
                <img src="https://images.unsplash.com/photo-1559839734-2b71ea197ec2?w=1400&q=80" alt="Healthcare worker with infant">
                <figcaption>Pediatric intensive care units that once filled with RSV patients are seeing dramatically fewer cases. Photo: Children's Hospital Association</figcaption>
            </figure>

            <h2>Protection Growing Throughout the Season</h2>

            <p>
                National immunization survey data shows the estimated proportion of U.S. infants aged 0-7 months protected by either maternal vaccination or nirsevimab increased throughout the 2024-25 RSV season—from 30% in October 2024 to 66% in February 2025. This uptake coincided with the hospitalization rate reductions.
            </p>

            <p>
                State-level data is equally impressive. In New York, RSV hospitalization rates in babies under 8 months decreased by 70 percent.
            </p>

            <p>
                The results support the recommendations of the Advisory Committee on Immunization Practices to optimize population-level impact by administering RSV prevention products as early as possible in the season.
            </p>

            <h2>A Scientific Breakthrough Decades in the Making</h2>

            <p>
                The RSV vaccines and antibody treatments represent the culmination of over 60 years of research. Scientists first identified RSV in 1956, and a vaccine attempt in the 1960s actually made the disease worse in some children—a setback that haunted the field for decades.
            </p>

            <p>
                The breakthrough came from understanding RSV's fusion protein—the key it uses to break into cells. By stabilizing this protein in its "pre-fusion" form, researchers created vaccines that generate powerful, protective antibodies.
            </p>

            <p>
                For now, pediatric wards across America are experiencing something they've never seen: a quieter RSV season. And for the parents of newborns, that's one less nightmare to lose sleep over—though, let's be honest, they'll find plenty of other reasons.
            </p>

            <div class="sources-box">
                <h3>Sources</h3>
                <ul>
                    <li><a href="https://www.cdc.gov/mmwr/volumes/74/wr/mm7416a1.htm" target="_blank">CDC MMWR: RSV Hospitalization Rates After Introduction of Prevention Products</a></li>
                    <li><a href="https://www.cdc.gov/rsv/php/surveillance/burden-estimates.html" target="_blank">CDC: Preliminary Estimates of RSV Burden for 2024-2025</a></li>
                    <li><a href="https://www.health.ny.gov/press/releases/2025/2025-05-09_respiratory_syncytial_virus.htm" target="_blank">NY State Department of Health: RSV Prevention Products Protect Infants</a></li>
                    <li><a href="https://www.aha.org/news/headline/2025-05-09-cdc-finds-lower-rsv-hospitalization-rates-infants-receiving-prevention-products" target="_blank">American Hospital Association: CDC Finds Lower RSV Hospitalization Rates</a></li>
                </ul>
            </div>
        </div>
    </article>

    <!-- Related Articles -->
    <section class="related-section">
        <div class="related-inner">
            <h2 class="related-title">More Health Stories</h2>
            <div class="related-grid">
                <a href="t-cell-therapy.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1579154204601-01588f351e67?w=600&q=80" alt="Laboratory research">
                    <div class="related-card-content">
                        <h4>FDA Set to Approve First Regulatory T Cell Therapy</h4>
                    </div>
                </a>
                <a href="malaria-vaccine.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1584036561566-baf8f5f1b144?w=600&q=80" alt="Vaccine vial">
                    <div class="related-card-content">
                        <h4>Malaria Vaccine Reaches 1 Million African Children</h4>
                    </div>
                </a>
                <a href="cancer-detection.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1576671081837-49000212a370?w=600&q=80" alt="Medical technology">
                    <div class="related-card-content">
                        <h4>Blood Test Can Now Detect 50 Types of Cancer Early</h4>
                    </div>
                </a>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="site-footer">
        <div class="footer-content">
            <div class="footer-brand">
                <div class="footer-logo"><span class="logo-left">NEWS THAT'S NOT</span><span class="logo-right">CRAP</span></div>
                <p class="footer-tagline">Doom-scrolling is so last decade. We bring you the breakthroughs, the victories, and the genuinely good stuff happening in the world.</p>
            </div>
            <nav class="footer-nav">
                <div class="footer-col">
                    <h4>Sections</h4>
                    <ul>
                        <li><a href="../climate.html">Climate</a></li>
                        <li><a href="../health.html">Health</a></li>
                        <li><a href="../science.html">Science</a></li>
                        <li><a href="../people.html">People</a></li>
                        <li><a href="../wildlife.html">Wildlife</a></li>
                        <li><a href="../cats.html">Cats</a></li>
                    </ul>
                </div>
                <div class="footer-col">
                    <h4>About</h4>
                    <ul>
                        <li><a href="../mission.html">Our Mission</a></li>
                        <li><a href="../team.html">Team</a></li>
                        <li><a href="../contact.html">Contact</a></li>
                    </ul>
                </div>
            </nav>
        </div>
        <div class="footer-bottom">
            <span>© 2026 News That's Not Crap. All the good vibes reserved.</span>
            <span class="footer-update">Updated daily at 6am Eastern</span>
        </div>
    </footer>
</body>
</html>
